Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Pityriasis lichenoides chronica in a Mexican pediatric series: clinical-epidemiological profile and therapeutic approach.

Created on 25 Aug 2026

Authors

Juan A Godínez-Chaparro, Helena Vidaurri-de la Cruz, Ixchel R Ramírez-Ricarte, Óscar G Aguirre-Félix

Published in

Boletin medico del Hospital Infantil de Mexico. Volume 83. Issue 4. Pages 279-286.

Abstract

Pityriasis lichenoides chronica (PLC) is a rare dermatosis in children, with limited epidemiological data restricting its clinical and therapeutic characterization.
A retrospective case series was conducted at two tertiary care hospitals in Mexico City. Electronic records of patients younger than 18 years of both sexes with a diagnosis of PLC confirmed by histopathology were included in the study. The study period was from January 2017 to March 2025.
Thirty-five confirmed cases were analysed (51.4% female and 48.6% male). The mean time to diagnosis was 2.4 years after lesion onset. The median disease duration was 24 months (interquartile ranges 9-49), with recurrence in 67.5% of cases. The most common sites were the trunk and extremities (65.7%), with predominance of erythematous-squamous papules and plaques (48.6%) that, upon resolution, left hypopigmented macules in 80% of patients. Phototherapy was used in 25.7% and oral methotrexate (MTX) in 22.9% of cases. In patients with prolonged disease duration (> 36 months), higher recurrence rates, longer MTX use, and, in some cases, greater use of phototherapy were observed.
Pediatric PLC in a Mexican case series showed a chronic and recurrent course, with a low rate of resolution. The high frequency of recurrences and therapeutic variability, including MTX and phototherapy in prolonged cases, highlights the need for standardized treatment protocols.

PMID:
42636476
Bibliographic data and abstract were imported from PubMed on 25 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement